OP015. Multicentre clinical trial with topical administration of the Toll-Like receptor 9 agonist DIMS0150 shows evidence for efficacy in moderate to severe Ulcerative Colitis | Zendy

AI Assistant Blog Pricing

OP015. Multicentre clinical trial with topical administration of the Toll-Like receptor 9 agonist DIMS0150 shows evidence for efficacy in moderate to severe Ulcerative Colitis

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.